logo
PROVIDERS
LABS
CROs
PAYORS
PATIENTS
ABOUT US
Schedule a Demo
Contact Us
Overview

Collaborations that Propel Innovation

From our early days, PGxAI recognized the importance of forging strategic alliances. Today, our partnerships and global market footprint underscore our commitment to transforming healthcare through secure, cutting-edge pharmacogenomics.
Market Reach
Why Work at PGxAI?
icon
Presence in Diverse Regions
PGxAI’s solutions are deployed across North America, Europe, and select Asia-Pacific markets, tailoring language and compliance to local requirements.
icon
Multilingual, Multi-Platform Support
Our platform accommodates various EHR, LIMS, and CRO data systems in different languages, adapting seamlessly to regional healthcare standards.
icon
Regulatory Alignment
Complies with HIPAA, SOC 2, and other international data protection frameworks—facilitating cross-border collaborations and global deployments.
The Road Ahead
Join Our Mission to Redefine Healthcare
By prioritizing data integrity, clinical accuracy, and a user-centric design, PGxAI continues to set new benchmarks for secure, AI-driven pharmacogenomics—empowering the healthcare ecosystem to make smarter, safer treatment decisions.
Rapid Revenue Growth
Rapid Revenue Growth
Early traction in oncology, cardiology, and psychiatry domains drives year-over-year adoption by health systems and labs.
Robust Client Feedback
Robust Client Feedback
Case studies indicate measurable drops in adverse drug events and significant improvements in trial success rates, reinforcing PGxAI’s market momentum.
Continual Innovation
Continual Innovation
Regular releases of expanded gene-drug coverage, enhanced AI models, and interoperable APIs keep PGxAI at the forefront of precision medicine.
Trusted by Leaders
Our Milestones & Partners
We collaborate with the world’s leading healthcare and tech organizations to bring advanced pharmacogenomic solutions to every corner of the globe
company logo
company logo
company logo
company logo
company logo
1M+
in Grants & Partnerships
12
Therapeutic Areas
50K+
Tests Conducted, Validated & Reimbursed
900+
Substances
150+
Genes Covered
Early Validation
As we continue to broaden our market presence, PGxAI remains dedicated to forming impactful partnerships that amplify the potential of AI-driven pharmacogenomics.
By uniting leading technology providers, healthcare institutions, and research organizations, we’re shaping an era of truly personalized care—one that prioritizes patient safety, cost-effectiveness, and seamless global collaboration.
Get in Touch
Ready to Shape the Future of Precision Medicine?